1. Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia.
- Author
-
Tsumuraya T, Ishikawa C, Machijima Y, Nakachi S, Senba M, Tanaka J, and Mori N
- Subjects
- Animals, Apoptosis drug effects, Apoptosis physiology, Cell Line, Transformed, Cell Line, Tumor, Cells, Cultured, DEAD-box RNA Helicases metabolism, Enzyme Inhibitors therapeutic use, Eukaryotic Initiation Factor-4A, Female, Human T-lymphotropic virus 1 drug effects, Human T-lymphotropic virus 1 physiology, Humans, Leukemia-Lymphoma, Adult T-Cell metabolism, Leukemia-Lymphoma, Adult T-Cell pathology, Mice, Mice, Inbred ICR, Mice, SCID, Sterols therapeutic use, DEAD-box RNA Helicases antagonists & inhibitors, Enzyme Inhibitors pharmacology, Leukemia-Lymphoma, Adult T-Cell drug therapy, Sterols pharmacology
- Abstract
We evaluated the anti-adult T-cell leukemia (ATL) effects of hippuristanol, an eukaryotic translation initiation inhibitor from the coral Isis hippuris. Hippuristanol inhibited proliferation of HTLV-1-infected T-cell lines and ATL cells, but not normal peripheral blood mononuclear cells. It induced cell cycle arrest during Gā phase by reducing the expression of cyclin D1, cyclin D2, CDK4 and CDK6, and induced apoptosis by reducing the expression of Bcl-x(L), c-IAP2, XIAP and c-FLIP. The induced apoptosis was associated with activation of caspase-3, -8 and -9. Hippuristanol also suppressed IkappaBalpha phosphorylation and depleted IKKalpha, IKKgamma, JunB and JunD, resulting in inactivation of NF-kappaB and AP-1. It also suppressed carbonic anhydrase type II expression. In addition to its in vitro effects, hippuristanol suppressed tumor growth in mice with severe combined immunodeficiency harboring tumors induced by inoculation of HTLV-1-infected T cells. These preclinical data suggest that hippuristanol could be a potentially useful therapeutic agent for patients with ATL., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF